0,838  0,004  Cardiovascular analeptic
0,633  0,014  Cholesterol antagonist
0,615  0,023  TNF expression inhibitor
0,602  0,017  Antihypercholesterolemic
0,569  0,010  Cardiodepressant
0,574  0,023  Aldehyde oxidase inhibitor
0,566  0,016  Spasmolytic
0,554  0,010  Vasodilator, coronary
0,544  0,012  Antiprotozoal (Leishmania)
0,547  0,019  Sensitization
0,540  0,022  Antipruritic, allergic
0,528  0,023  Vasodilator, peripheral
0,522  0,020  Calcium channel L-type activator
0,509  0,010  UGT2B4 substrate
0,515  0,019  UGT1A9 substrate
0,503  0,028  Histamine release inhibitor
0,494  0,021  Lipoprotein disorders treatment
0,492  0,035  5 Hydroxytryptamine release inhibitor
0,477  0,021  NOS2 expression inhibitor
0,451  0,019  Tumour necrosis factor alpha release inhibitor
0,511  0,083  Antiinflammatory
0,447  0,025  Interleukin antagonist
0,496  0,076  Apoptosis agonist
0,439  0,021  Nitric oxide antagonist
0,449  0,032  FMO1 substrate
0,434  0,031  Analeptic
0,420  0,018  Calcium channel activator
0,449  0,050  Antiprotozoal
0,440  0,041  Ulceration
0,457  0,064  Cyclophilin D inhibitor
0,457  0,064  Antidiabetic
0,404  0,015  Abortion inducer
0,419  0,032  Antioxidant
0,407  0,022  Antimitotic
0,426  0,043  Antiprotozoal (Plasmodium)
0,394  0,012  Antihypotensive
0,382  0,005  Interleukin 1b antagonist
0,417  0,042  5 Hydroxytryptamine release stimulant
0,455  0,080  Caspase 9 stimulant
0,381  0,013  Melanin inhibitor
0,403  0,040  Antihypertensive
0,389  0,031  Radiosensitizer
0,379  0,022  Interleukin agonist
0,358  0,007  Bronchodilator
0,406  0,061  CYP3A4 substrate
0,357  0,017  UGT2B7 substrate
0,369  0,030  UGT1A6 substrate
0,334  0,004  UGT2B10 substrate
0,378  0,049  CYP2D6 substrate
0,342  0,016  VCAM1 expression inhibitor
0,374  0,052  Hepatic disorders treatment
0,371  0,050  Respiratory analeptic
0,332  0,015  Amylase inhibitor
0,354  0,037  Hypoglycemic
0,335  0,019  Antiseptic
0,340  0,024  Eye irritation, high
0,321  0,010  Sulfotransferase substrate
0,331  0,021  Antiviral (Herpes)
0,323  0,018  Skeletal muscle relaxant
0,351  0,049  CTGF expression inhibitor
0,324  0,024  Hepatoprotectant
0,306  0,008  Neurotrophic factor
0,311  0,014  Insulin sensitizer
0,332  0,038  Vascular (periferal) disease treatment
0,309  0,016  Neurotrophic factor enhancer
0,295  0,005  Calcium antagonist
0,330  0,041  Hypolipemic
0,311  0,022  Skin irritative effect
0,316  0,029  UGT1A1 substrate
0,360  0,073  Stroke treatment
0,302  0,017  Genotoxic
0,337  0,052  Interleukin 2 agonist
0,313  0,029  Muscle relaxant
0,293  0,012  Cholesterol synthesis inhibitor
0,332  0,052  Sodium/bile acid cotransporter inhibitor
0,282  0,005  Electron transport complex I inhibitor
0,287  0,013  Interleukin 1 antagonist
0,295  0,022  UGT1A3 substrate
0,324  0,051  Chemoprotective
0,296  0,026  Peptidyltransferase inhibitor
0,339  0,068  Antithrombotic
0,279  0,014  Antihyperlipoproteinemic
0,287  0,022  Hair growth stimulant
0,306  0,041  Psychostimulant
0,320  0,056  Hypoxia-inducible factor 1 alpha inhibitor
0,350  0,087  Immunosuppressant
0,298  0,035  Septic shock treatment
0,322  0,059  CYP1A2 substrate
0,268  0,008  VEGF expression inhibitor
0,276  0,020  CNS active muscle relaxant
0,287  0,031  P-glycoprotein inhibitor
0,336  0,081  Transcription factor NF kappa B inhibitor
0,290  0,036  Anesthetic general
0,337  0,084  Antineoplastic (lung cancer)
0,303  0,065  CYP2C19 substrate
0,289  0,053  Antiglaucomic
0,279  0,046  Chemopreventive
0,243  0,011  Alcohol dehydrogenase substrate
0,244  0,013  Expectorant
0,310  0,083  ICAM1 expression inhibitor
0,269  0,042  Sedative
0,245  0,022  UGT2B9 substrate
0,247  0,027  Protein kinase stimulant
0,319  0,101  GST A substrate
0,272  0,058  Vasodilator
0,291  0,079  NOS3 expression inhibitor
0,231  0,020  SULT1A3 substrate
0,248  0,039  Antimutagenic
0,225  0,017  Antirickettsial
0,282  0,074  Radioprotector
0,273  0,066  Embryotoxic
0,235  0,029  Skin whitener
0,215  0,012  Coagulant
0,241  0,039  Antipruritic, non-allergic
0,260  0,059  Cyclic AMP phosphodiesterase inhibitor
0,233  0,032  Antiparkinsonian, tremor relieving
0,268  0,071  Teratogen
0,207  0,012  Mucolytic
0,295  0,104  Antileukemic
0,286  0,096  Antineoplastic (endocrine cancer)
0,193  0,005  Paget's disease treatment
0,234  0,046  UGT1A4 substrate
0,190  0,005  UGT2B11 substrate
0,195  0,011  Sphingomyelinase inhibitor
0,250  0,069  Free radical scavenger
0,241  0,060  Antihypertriglyceridemic
0,187  0,008  Phenylalanine 4-hydroxylase inhibitor
0,229  0,050  Nitric-oxide synthase stimulant
0,252  0,074  Proliferative diseases treatment
0,196  0,018  Choleretic
0,232  0,055  UDP-glucuronosyltransferase substrate
0,218  0,045  Antianorexic
0,207  0,035  Tubulin antagonist
0,208  0,040  UGT2B15 substrate
0,203  0,039  Anesthetic
0,168  0,005  Beta adrenoreceptor antagonist
0,197  0,034  Monophenol monooxygenase inhibitor
0,236  0,073  Cytostatic
0,184  0,023  Adenylate cyclase stimulant
0,188  0,030  Toll-Like receptor 2 antagonist
0,185  0,027  Chelator
0,180  0,024  Growth stimulant
0,191  0,035  Anesthetic local
0,181  0,026  MAP3K9 inhibitor
0,167  0,011  Adrenaline agonist
0,203  0,051  LDLR expression enhancer
0,181  0,030  Antieczematic
0,179  0,028  Cyclooxygenase 3 inhibitor
0,190  0,040  Carcinogenic, group 1
0,275  0,126  CYP2C9 substrate
0,173  0,026  SULT1A1 substrate
0,190  0,043  Arachidonic acid antagonist
0,176  0,029  Antiadrenergic
0,193  0,046  Phospholipase A2 inhibitor
0,173  0,029  Adrenaline antagonist
0,156  0,013  Acetylcholine release stimulant
0,164  0,024  UGT2B1 substrate
0,145  0,005  Beta 1 adrenoreceptor antagonist
0,204  0,064  CYP2B6 inhibitor
0,194  0,054  Succinate dehydrogenase inhibitor
0,144  0,006  Beta 3 adrenoreceptor antagonist
0,154  0,017  Antifungal (Pneumocystis)
0,188  0,051  Antineoplastic (bone cancer)
0,160  0,024  Aldehyde dehydrogenase substrate
0,166  0,030  Microtubule formation inhibitor
0,228  0,093  Tyrosine 3 hydroxylase inhibitor
0,160  0,029  Vanilloid 1 agonist
0,184  0,054  Acaricide
0,209  0,081  Antiparasitic
0,139  0,012  Leukotriene antagonist
0,169  0,042  Topoisomerase II inhibitor
0,189  0,062  Peroxidase inhibitor
0,149  0,026  Chronic obstructive bronchitis treatment
0,170  0,046  Bone formation stimulant
0,219  0,098  Superoxide dismutase inhibitor
0,125  0,007  Leukotriene B4 antagonist
0,144  0,029  Antiinfertility, female
0,201  0,087  Antiulcerative
0,142  0,028  Catalase inhibitor
0,193  0,081  Pneumotoxic
0,169  0,057  Insulin secretagoues
0,167  0,055  Antidiarrheal
0,192  0,080  Antiarrhythmic
0,220  0,109  Immunostimulant
0,161  0,051  Nav1.2 sodium channel blocker
0,238  0,128  Antineoplastic (brain cancer)
0,142  0,033  Mediator release inhibitor
0,231  0,123  Antifungal
0,152  0,044  Antitussive
0,125  0,019  Peroxisome proliferator-activated receptor gamma agonist
0,110  0,005  Acetyl-CoA transferase 2 inhibitor
0,216  0,112  Antineoplastic (ovarian cancer)
0,170  0,068  Muscular dystrophy treatment
0,212  0,116  Amyotrophic lateral sclerosis treatment
0,104  0,007  Beta 2 adrenoreceptor antagonist
0,120  0,024  Interleukin 5 antagonist
0,136  0,041  Photosensitizer
0,105  0,011  Peroxisome proliferator-activated receptor alpha agonist
0,195  0,103  Antineoplastic (glioma)
0,159  0,067  Interferon gamma antagonist
0,209  0,118  Antineoplastic (melanoma)
0,103  0,014  Peroxisome proliferator-activated receptor gamma antagonist
0,121  0,033  Phosphodiesterase IV inhibitor
0,108  0,021  Sphingosine 1-phosphate receptor 4 agonist
0,094  0,007  Calcium channel P-type blocker
0,135  0,048  Contraceptive female
0,105  0,019  Estrogen-related receptor beta agonist
0,214  0,130  Antiischemic
0,099  0,016  Endocannabinoid uptake inhibitor
0,147  0,067  Antineoplastic (squamous cell carcinoma)
0,156  0,077  Uterine stimulant
0,178  0,099  Platelet aggregation inhibitor
0,163  0,086  Myocardial ischemia treatment
0,166  0,088  Carcinogenic
0,095  0,017  Neuraminidase inhibitor
0,176  0,099  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,136  0,060  Antibacterial (Helicobacter pylori)
0,111  0,035  Phosphodiesterase 6D inhibitor
0,180  0,105  Angiogenesis stimulant
0,126  0,051  Caspase 3 inhibitor
0,217  0,144  AR expression inhibitor
0,118  0,045  Gastric antisecretory
0,108  0,036  Ornithine decarboxylase inhibitor
0,158  0,087  Antianginal
0,161  0,091  Antineoplastic (gastric cancer)
0,183  0,113  Antineoplastic (cervical cancer)
0,089  0,020  Neuraminidase (influenza) inhibitor
0,167  0,098  Non-steroidal antiinflammatory agent
0,075  0,007  Sphingosine 1-phosphate receptor 1 agonist
0,108  0,040  Toll-Like receptor 3 antagonist
0,092  0,024  GABA B receptor agonist
0,078  0,010  Beta 2 adrenoreceptor agonist
0,073  0,007  Prostaglandin agonist
0,099  0,034  Vanilloid agonist
0,096  0,032  Glutamate decarboxylase inhibitor
0,074  0,010  Sphingosine 1-phosphate receptor agonist
0,126  0,063  Alkylator
0,078  0,017  Sphingosine kinase inhibitor
0,190  0,129  Antineoplastic (colon cancer)
0,113  0,053  Nav1.1 sodium channel blocker
0,127  0,068  Antineoplastic (uterine cancer)
0,213  0,154  Angiogenesis inhibitor
0,102  0,043  Aminoacyl-tRNA synthetase inhibitor
0,153  0,095  Aldehyde oxidase substrate
0,144  0,086  Aldose reductase substrate
0,195  0,137  Antineoplastic (colorectal cancer)
0,135  0,079  Lipid peroxidase inhibitor
0,062  0,007  Beta adrenoreceptor agonist
0,271  0,217  Antineoplastic (solid tumors)
0,202  0,148  5 Hydroxytryptamine uptake stimulant
0,105  0,052  GST P1-1 substrate
0,068  0,015  Lysophosphatidic acid 3 receptor antagonist
0,090  0,037  Keratolytic
0,115  0,063  Sphingosine 1-phosphate receptor 2 agonist
0,140  0,088  Raynaud's phenomenon treatment
0,127  0,076  Interleukin 4 antagonist
0,063  0,011  Sphingosine 1-phosphate receptor 3 agonist
0,073  0,022  Sphingosine 1-phosphate receptor 3 antagonist
0,078  0,029  Uterine relaxant
0,078  0,029  Exportin-1 inhibitor
0,122  0,073  Gastritis treatment
0,083  0,036  Phosphodiesterase VI inhibitor
0,076  0,029  Prostaglandin EP2 antagonist
0,064  0,018  Anesthetic inhalation
0,177  0,132  Antineoplastic (liver cancer)
0,188  0,143  Antiviral (West Nile virus)
0,115  0,072  Acetylcholine muscarinic antagonist
0,049  0,006  Sodium/glucose cotransporter 2 inhibitor
0,212  0,169  GST M1-1 substrate
0,215  0,173  Antineoplastic (breast cancer)
0,063  0,022  Sphingosine 1-phosphate receptor 5 agonist
0,135  0,094  Ca2+-transporting ATPase inhibitor
0,093  0,052  Antiviral (Hepatitis A)
0,045  0,006  Sodium/glucose cotransporter inhibitor
0,208  0,169  Apoptosis antagonist
0,061  0,022  Vanilloid 2 antagonist
0,065  0,026  Sphingosine kinase 2 inhibitor
0,103  0,066  Glutathione S-transferase substrate
0,050  0,013  Vesicle monoamine transporter inhibitor
0,171  0,135  Antipyretic
0,114  0,077  Aldehyde dehydrogenase inhibitor
0,048  0,012  Cholesterol absorption inhibitor
0,117  0,081  Alpha-N-acetylglucosaminidase inhibitor
0,069  0,034  Antiviral (Parainfluenza)
0,087  0,051  Glutathione S-transferase inhibitor
0,060  0,026  Alpha-mannosidase inhibitor
0,082  0,048  Interferon agonist
0,050  0,016  Sphingosine kinase 1 inhibitor
0,039  0,005  Sodium/glucose cotransporter 1 inhibitor
0,044  0,010  Lysophosphatidic acid 2 receptor antagonist
0,079  0,046  SULT1A2 substrate
0,038  0,005  Beta 1 adrenoreceptor agonist
0,040  0,007  Prostaglandin E2 agonist
0,125  0,094  Antiischemic, cerebral
0,039  0,008  Follicle-stimulating hormone agonist
0,067  0,036  Beta tubulin antagonist
0,186  0,155  Lipoxygenase inhibitor
0,141  0,111  Cytotoxic
0,068  0,038  Interferon inducer
0,060  0,031  Alpha tubulin antagonist
0,052  0,024  Mannosidase inhibitor
0,044  0,017  Phosphoglycerate kinase inhibitor
0,096  0,068  Anabolic
0,037  0,010  Prostaglandin EP2 agonist
0,067  0,041  Hypercalcemia treatment
0,163  0,138  Antineoplastic (non-small cell lung cancer)
0,106  0,080  DNA polymerase I inhibitor
0,033  0,007  Prostaglandin F2 alpha agonist
0,058  0,032  Myc inhibitor
0,031  0,006  Lysophosphatidic acid 1 receptor antagonist
0,039  0,014  Cholesterol ester transfer protein antagonist
0,237  0,212  Antiarthritic
0,058  0,034  Sphingosine 1-phosphate receptor 1 antagonist
0,076  0,052  Antitreponemal
0,056  0,033  Acetyl-CoA transferase inhibitor
0,030  0,007  Prostaglandin EP4 agonist
0,196  0,175  Caspase 3 stimulant
0,085  0,064  Tocolytic
0,039  0,018  Peroxisome proliferator-activated receptor delta agonist
0,093  0,072  Antifungal (Candida)
0,031  0,010  Lysophosphatidic acid receptor 1 agonist
0,035  0,015  Leukotriene B4 receptor 1 antagonist
0,050  0,030  Adenosine deaminase inhibitor
0,086  0,065  ATPase (Vacuolar H+) inhibitor
0,036  0,016  Prostaglandin D2 agonist
0,042  0,022  Diamine oxidase inhibitor
0,099  0,081  Multidrug resistance-associated protein 1 inhibitor
0,061  0,044  Antimycoplasmal
0,212  0,195  Antiobesity
0,023  0,007  Follicle-stimulating hormone antagonist
0,046  0,030  Neuraminidase (Influenza A) inhibitor
0,094  0,079  HDL-cholesterol increasing
0,177  0,163  Prostate cancer treatment
0,135  0,121  Amyloid beta aggregation inhibitor
0,136  0,123  Platelet adhesion inhibitor
0,041  0,028  Acetyl-CoA transferase 1 inhibitor
0,063  0,050  Purinergic P2X2 antagonist
0,071  0,057  Carbonic anhydrase XIII inhibitor
0,026  0,013  Peroxisome proliferator-activated receptor alpha antagonist
0,061  0,048  Hyperparathyroidism treatment
0,100  0,087  Proteasome inhibitor
0,046  0,034  Potassium channel Kv1.3 blocker
0,033  0,021  Nucleoside transporters inhibitor
0,055  0,043  Leukotriene C antagonist
0,138  0,126  Antihelmintic
0,089  0,077  Bile acid receptor antagonist
0,033  0,021  Estrogen-related receptor beta antagonist
0,155  0,145  Antineoplastic enhancer
0,018  0,009  Calcium-sensing receptor antagonist
0,033  0,024  Peroxisome proliferator-activated receptor delta antagonist
0,019  0,010  G-protein-coupled receptor 120 agonist
0,083  0,075  Breast cancer-resistant protein inhibitor
0,019  0,011  Antibiotic Trimethoprim-like
0,181  0,173  Bone diseases treatment
0,028  0,021  1,3-Beta-glucan synthase inhibitor
0,156  0,149  Antineoplastic (renal cancer)
0,085  0,078  Antiviral (Rhinovirus)
0,033  0,026  Purinergic P2X3 antagonist
0,161  0,154  Antidiabetic symptomatic
0,026  0,021  Uridine phosphorylase inhibitor
0,117  0,113  Antiprotozoal (Coccidial)
0,074  0,070  Antispirochetal
0,163  0,160  Cardiotonic
0,054  0,051  Cathepsin E inhibitor
0,080  0,076  Triose-phosphate isomerase inhibitor
0,016  0,013  Ileal bile acid transport inhibitor
0,016  0,013  Vitamin D receptor agonist
0,021  0,018  Vitamin D receptor antagonist
0,100  0,097  Nav1.3 sodium channel blocker
0,081  0,079  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,115  0,113  Antidote
0,122  0,120  Neuropathy treatment
0,099  0,097  Cholinergic antagonist
0,062  0,060  Gaucher disease treatment
0,063  0,062  Anticholelithogenic
0,151  0,150  Urologic disorders treatment

